Acrux Ltd
ASX:ACR

Watchlist Manager
Acrux Ltd Logo
Acrux Ltd
ASX:ACR
Watchlist
Price: 0.015 AUD -6.25% Market Closed
Market Cap: 6.1m AUD

Gross Margin
Acrux Ltd

100%
Current
66%
Average
48.7%
Industry
Created with Highcharts 11.4.8Jul '19Jan '20Jul '20Jan '21Jul '21Jan '22Jul '22Jan '23Jul '23Jan '24Jul '24Jan '25Jul '250%25%50%75%100%

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
100%
=
Gross Profit
4.5m
/
Revenue
4.5m

Gross Margin Across Competitors

Country Company Market Cap Gross
Margin
AU
Acrux Ltd
ASX:ACR
6.1m AUD
100%
US
Eli Lilly and Co
NYSE:LLY
1T USD
83%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
56%
US
Johnson & Johnson
NYSE:JNJ
490.6B USD
68%
CH
Roche Holding AG
SIX:ROG
248.4B CHF
74%
UK
AstraZeneca PLC
LSE:AZN
214.4B GBP
82%
CH
Novartis AG
SIX:NOVN
197.5B CHF
76%
US
Merck & Co Inc
NYSE:MRK
243.2B USD
79%
DK
Novo Nordisk A/S
CSE:NOVO B
1.2T DKK
82%
IE
Endo International PLC
LSE:0Y5F
202B USD
68%
US
Pfizer Inc
NYSE:PFE
142.4B USD
75%

Acrux Ltd
Glance View

Market Cap
6.1m AUD
Industry
Pharmaceuticals

Acrux Ltd. operates as a pooled development fund that invests in pharmaceutical businesses. The company is headquartered in Melbourne, Victoria. The company went IPO on 2004-09-29. The firm is engaged in developing and commercializing a portfolio of generic topical prescription pharmaceutical products which use dermal and transdermal drug delivery technology. The firm's product pipeline includes Evamist, Lenzetto, Jublia, EMLA and Testosterone Topical Solution. The firm's transdermal or topical pharmaceutical product portfolio can be segregated into approximately two streams, such as generic pharmaceutical products and specialty pharmaceutical products. The products offered by the Company are the testosterone topical solution to treat adult males who have low or no testosterone and Estradiol MDTS to treat moderate to severe hot flushes commonly associated with menopause. The company is also developing a range of topical and dermatological generic products for the United States market. The firm operates in the United States, Europe and other markets.

ACR Intrinsic Value
0.139 AUD
Undervaluation 89%
Intrinsic Value
Price
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
100%
=
Gross Profit
4.5m
/
Revenue
4.5m
What is the Gross Margin of Acrux Ltd?

Based on Acrux Ltd's most recent financial statements, the company has Gross Margin of 100%.

Back to Top